Garden State Investment Advisory Services »

Biosante Pharmaceuticals shares owned by Garden State Investment Advisory Services

Quarter-by-quarter ownership of Biosante Pharmaceuticals (ANIP) shares owned by Garden State Investment Advisory Services from 13F filings

Historical chart of Garden State Investment Advisory Services investment in Biosante Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Biosante Pharmaceuticals held by Garden State Investment Advisory Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biosante Pharmaceuticals by Garden State Investment Advisory Services

Quarter filed Position value Share count Share price at filing
2026-06-30 $261k 3.1k 82.78

More positions owned by Garden State Investment Advisory Services

Invesco Exchange Traded Fd T Larg Cap Gro Etf (PWB)
NVIDIA Corporation (NVDA)
T Rowe Price Exchange-traded Us Equi Resh Etf (TSPA)
Series Portfolios Tr Equab Equit Etf (HEDG)
Invesco Qqq Tr Unit Ser 1 (QQQ)
State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Amazon (AMZN)
Micron Technology Put Option (MU)
Palantir Technologies Cl A (PLTR)
Meta Platforms Cl A Call Option (META)
Apple (AAPL)
Advanced Micro Devices (AMD)
Broadcom Call Option (AVGO)
T Rowe Price Exchange-traded Cap Appreciation (TCAF)
J P Morgan Exchange Traded F Nasdaq Eqt Prem (JEPQ)

View all positions for Garden State Investment Advisory Services

Top funds holding Biosante Pharmaceuticals

BlackRock
Soleus Capital Management
Vanguard Capital Management
State Street Corporation
Tang Capital Management
Dimensional Fund Advisors
American Century Companies
Arrowstreet Capital, Limited Partnership
Global Alpha Capital Management
Geode Capital Management
Millennium Management
Nuveen
Vanguard Portfolio Management
Ranger Investment Management
Deutsche Bank Aktiengesellschaft

View all funds holding Biosante Pharmaceuticals